Brokerages Set Humana Inc. (NYSE:HUM) Price Target at $579.00

Humana Inc. (NYSE:HUMGet Rating) has been given an average rating of “Moderate Buy” by the eighteen analysts that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $579.00.

A number of research firms have weighed in on HUM. The Goldman Sachs Group increased their price objective on Humana from $522.00 to $575.00 and gave the stock a “neutral” rating in a research report on Thursday, November 3rd. Royal Bank of Canada raised their price target on Humana from $560.00 to $637.00 and gave the stock an “outperform” rating in a research report on Thursday, November 3rd. SVB Leerink lifted their price objective on Humana from $540.00 to $640.00 and gave the company an “outperform” rating in a research report on Thursday, November 3rd. Wells Fargo & Company lifted their target price on Humana from $558.00 to $610.00 in a report on Tuesday, November 8th. Finally, Cowen lifted their target price on Humana from $547.00 to $647.00 in a report on Monday, November 7th.

Humana Trading Up 1.4 %

HUM opened at $538.30 on Tuesday. The company has a market cap of $68.15 billion, a P/E ratio of 24.41, a PEG ratio of 1.50 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.35 and a current ratio of 1.35. Humana has a one year low of $351.20 and a one year high of $571.30. The business’s 50-day simple moving average is $517.29 and its 200-day simple moving average is $484.93.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Friday, December 30th will be given a $0.7875 dividend. This represents a $3.15 annualized dividend and a yield of 0.59%. The ex-dividend date of this dividend is Thursday, December 29th. Humana’s payout ratio is currently 14.29%.

Insider Activity at Humana

In related news, CAO William Kevin Fleming sold 11,157 shares of Humana stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $565.61, for a total value of $6,310,510.77. Following the completion of the sale, the chief accounting officer now owns 2,542 shares of the company’s stock, valued at approximately $1,437,780.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CAO William Kevin Fleming sold 11,157 shares of Humana stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $565.61, for a total value of $6,310,510.77. Following the completion of the sale, the chief accounting officer now owns 2,542 shares of the company’s stock, valued at approximately $1,437,780.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Joseph C. Ventura sold 1,226 shares of Humana stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $506.78, for a total transaction of $621,312.28. Following the completion of the sale, the insider now directly owns 3,930 shares of the company’s stock, valued at approximately $1,991,645.40. The disclosure for this sale can be found here. In the last 90 days, insiders sold 30,161 shares of company stock valued at $16,994,804. 0.39% of the stock is owned by company insiders.

Hedge Funds Weigh In On Humana

Hedge funds have recently bought and sold shares of the company. Townsend & Associates Inc purchased a new position in Humana during the 2nd quarter worth $206,000. Krane Funds Advisors LLC boosted its holdings in shares of Humana by 4.2% in the 1st quarter. Krane Funds Advisors LLC now owns 889 shares of the insurance provider’s stock worth $387,000 after buying an additional 36 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of Humana by 32.3% in the 2nd quarter. Private Advisor Group LLC now owns 15,520 shares of the insurance provider’s stock worth $7,265,000 after buying an additional 3,788 shares during the last quarter. CCLA Investment Management Ltd boosted its holdings in shares of Humana by 1.4% in the 1st quarter. CCLA Investment Management Ltd now owns 218,232 shares of the insurance provider’s stock worth $95,075,000 after buying an additional 3,034 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of Humana by 2.3% in the 2nd quarter. Envestnet Asset Management Inc. now owns 57,029 shares of the insurance provider’s stock worth $26,694,000 after buying an additional 1,282 shares during the last quarter. 93.50% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.